NCT00982657 2015-11-20A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell CarcinomaPfizerPhase 2 Terminated34 enrolled 10 charts
NCT00392444 2014-05-21Sunitinib in Treating Patients With Advanced Malignant Pleural MesotheliomaNational Cancer Institute (NCI)Phase 2 Completed39 enrolled 5 charts